Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Fuzzy Decision Making in Toxoplasmosis Medication
Blekinge Institute of Technology, School of Engineering, Department of Mathematics and Natural Sciences.ORCID iD: 0000-0002-9920-7946
Responsible organisation
2012 (English)In: New Developments in Fuzzy Sets, Intuitionistic Fuzzy Sets, Generalized Nets and Related Topics / [ed] K., Atanassov; W., Homenda; O., Hryniewicz; J., Kacprzyk; M., Krawczak; Z., Nahorski; E., Szmidt; S., Zadrozny, Warsaw: Polish Academy of Sciences, System Research Institute , 2012, p. 185-200Chapter in book (Refereed)
Abstract [en]

Theoretical fuzzy decision-making models mostly developed by Zadeh, Bellman, Jain and Yager can be adopted as useful tools to estimation of the total effectiveness-utility of a drug when appreciating its positive influence on a collection of symptoms characteristic of a considered diagnosis. The expected effectiveness of the medicine is evaluated by a physician as a verbal expression for each distinct symptom. By converting the words at first to fuzzy sets and then numbers we can regard the effectiveness structures as entries of a utility matrix that constitutes the common basic component of all methods. We involve the matrix in a number of computations due to different decision algorithms to obtain a sequence of tested medicines in conformity with their abilities to soothe the unfavorable impact of symptoms. An adjustment of the large spectrum of applied fuzzy decision-making models to the extraction of the best medicines provides us with some deviations in obtained results but we are thus capable to select this method whose effects closest converge to the physicians’ judgments and expectations. In the current paper we apply fuzzy decision making algorithms to rank medicines in multifocal toxoplasmosis.

Place, publisher, year, edition, pages
Warsaw: Polish Academy of Sciences, System Research Institute , 2012. p. 185-200
Keywords [en]
Fuzzy decision-making, Fuzzy utility matrix, Powers of symptom importance, Utilities of medicines in toxoplasmosis, Bellman-Zadeh decision making, Unequal objectives, Minimization of regret, OWA operators.
National Category
Mathematics Medical and Health Sciences
Identifiers
URN: urn:nbn:se:bth-7269Local ID: oai:bth.se:forskinfo2B85FD3AE08F1731C1257A4F0041EEE2ISBN: 83-894-7541-3 (print)OAI: oai:DiVA.org:bth-7269DiVA, id: diva2:834860
Available from: 2012-09-18 Created: 2012-08-03 Last updated: 2016-09-20Bibliographically approved

Open Access in DiVA

No full text in DiVA

Authority records

Rakus-Andersson, Elisabeth

Search in DiVA

By author/editor
Rakus-Andersson, Elisabeth
By organisation
Department of Mathematics and Natural Sciences
MathematicsMedical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

isbn
urn-nbn

Altmetric score

isbn
urn-nbn
Total: 96 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf